[1] Khanna R, Sarin SK.Noncirrhotic portal hypertension: current and emerging perspectives. Clin Liver Dis, 2019, 23(4):781-807. [2]Sarin SK, Kumar A, Chawla YK, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int, 2007, 1(3):398-413. [3] Eichholz JC, Kirstein MM, Book T, et al. Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis. Eur J Gastroenterol Hepatol, 2020[ahead of print]. [4] Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. J Dig Dis, 2014, 15(3):105-107. [5] Da BL, Surana P, Kapuria D, et al. Portal pressure in noncirrhotic portal hypertension: to measure or not to measure. Hepatology, 2019, 70(6):2228-2230. [6] Lee H, Ainechi S, Singh M, et al. Histological spectrum of idiopathic noncirrhotic portal hypertension in liver biopsies from dialysis patients. Int J Surg Pathol, 2015, 23(6):439-446. [7] Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Semin Diagn Pathol, 2019, 36(6):395-403. [8] 中华医学会消化病学分会肝胆疾病协作组. 吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京). 中华消化内镜杂志, 2017, 34(8):533-542. [9] Da BL, Koh C, Heller T. Noncirrhotic portal hypertension. Curr Opin Gastroenterol, 2018, 34(3):140-145. [10] Khanna R, Sarin SK. Non-cirrhotic portal hypertension-diagnosis and management. J Hepatol, 2014, 60(2):421-441. [11] 熊清芳, 杨永峰. 不明原因胆汁淤积诊断思路. 实用肝脏病杂志, 2018, 21(1):18-20. [12] European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol, 2017, 67(1):145-172. [13] Vilarinho S, Sari S, Yilmaz G, et al. Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension. Hepatology, 2016, 63(6):1977-1986. [14] Gao N, Zhao Z, Che F, et al. Posterior reversible encephalopathy syndrome and idiopathic noncirrhotic portal hypertensionin a patient with systemic sclerosis. J Clin Rheumatol, 2019[ahead of print]. [15] Goel A, Ramakrishna B, Muliyil J, et al. Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.Dig Dis Sci, 2013, 58(1):179-187. [16] Felli E, Saviano A, Tripon S, et al. Letter to the editor: abdominal surgery in idiopathic noncirrhotic portal hypertension: is preemptive TIPS reducing postoperative complications? Hepatology, 2020, 71(4):1520-1522. [17] Sahin A, Artas H, Tunc N, et al. Hematological indices in portal hypertension: cirrhosis versus noncirrhotic portal hypertension. J Clin Med, 2018, 7(8):196. [18] Elkrief L, Ferrusquia-Acosta J, Payancé A, et al. Abdominal surgery in patients with idiopathic noncirrhotic portal hypertension: a multicenter retrospective study. Hepatology, 2019, 70(3):911-924. [19] Nakazawa T, Notohara K, Tazuma S, et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol, 2017, 52(7):838-844. [20] Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int, 2018, 12(Suppl 1):148-167. |